Is Essential Thrombocythemia hereditary?

Essential Thrombocythemia is typically a sporadic, acquired condition rather than a hereditary one, meaning it is caused by somatic mutations that occur during a person's lifetime rather than being passed down from parents. While Essential Thrombocythemia is a genetic disease in the sense that it is driven by DNA changes in blood-forming cells, these mutations are not present in every cell of the body and are not inherited by children.

Is Essential Thrombocythemia hereditary?

Most cases of Essential Thrombocythemia are not hereditary. The condition arises from somatic mutations—acquired genetic changes—that occur in hematopoietic stem cells during a person's life. Because these mutations are limited to the bone marrow and blood cells, they are not passed to offspring. While rare "familial" cases of Essential Thrombocythemia do exist, they represent a very small fraction of total diagnoses and usually follow an autosomal dominant inheritance pattern, though the specific genes involved are often distinct from those in sporadic cases.

What causes the genetic changes in Essential Thrombocythemia?

The majority of patients with Essential Thrombocythemia have acquired mutations in one of three primary genes:

• JAK2 (Janus kinase 2): Found in approximately 50–60% of patients.


• CALR (Calreticulin): Found in approximately 15–24% of patients.


• MPL (Myeloproliferative leukemia virus oncogene): Found in approximately 3–5% of patients.

Is genetic testing recommended for Essential Thrombocythemia?

Genetic testing is a standard part of the diagnostic process for Essential Thrombocythemia. Hematologists use these tests to identify the specific driver mutation (JAK2, CALR, or MPL), which helps confirm the diagnosis, assess disease risk, and guide treatment decisions involving medications like Hydrea or aspirin. Because the condition is almost always sporadic, routine genetic counseling is generally not required for family members unless there is a strong, documented family history of myeloproliferative neoplasms.

Can Essential Thrombocythemia be passed to children?

Because Essential Thrombocythemia is caused by acquired (somatic) mutations in the bone marrow, it is not considered a hereditary condition. There is no evidence that children of a parent with Essential Thrombocythemia are at an increased risk of developing the disease. Consequently, carrier testing and prenatal diagnosis are not standard clinical recommendations for this condition.

Next steps

• Consult with a hematologist to discuss your specific molecular profile and treatment plan.


• Connect with the 325 members of the DiseaseMaps.org community to share experiences.


• Discuss any concerns regarding family history with a genetic counselor if multiple relatives have been diagnosed with blood disorders.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: Essential Thrombocythemia


• OMIM (Online Mendelian Inheritance in Man) entry for Essential Thrombocythemia


• MPN Research Foundation